Artwork

Innhold levert av Managed Care Cast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Managed Care Cast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

This Week in Managed Care—Stakeholders Weigh in on Drug Pricing Plan and Other Health News

5:01
 
Del
 

Manage episode 213294051 series 1314490
Innhold levert av Managed Care Cast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Managed Care Cast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care stories included patient advocates, providers, payers, and pharma commenting on the Trump administration's drug pricing plan; a survey that found physicians and payers believe progress toward value-based care is slowing; a study that questions the standards of evidence for breakthrough therapy approvals. Read more about the stories in this podcast: From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs: https://www.ajmc.com/newsroom/from-patient-advocates-to-pharma-groups-weigh-in-on-trump-blueprint-for-drug-costs Novartis Will Freeze Drug Prices Through End of 2018, CEO Says: https://www.ajmc.com/newsroom/novartis-will-freeze-drug-prices-through-end-of-2018-ceo-says What We're Reading: 340B Lawsuit to Be Refiled; Digging Into Breakthrough Approvals; Screen Time and ADHD: https://www.ajmc.com/newsroom/what-were-reading-340b-lawsuit-to-be-refiled-digging-into-breakthrough-approvals-screen-time-and-adhd Pause in Risk Adjustment Payments Announced, CMS Blames District Court's Decision: https://www.ajmc.com/newsroom/pause-in-risk-adjustment-payments-announced-cms-blames-district-courts-decision Doctors, Payers Think Transition to Value-Based Care Has Slowed, Survey Says: https://www.ajmc.com/newsroom/doctors-payers-think-transition-to-valuebased-care-has-slowed-survey-says Do Breakthrough Therapies Need More Rigorous Evaluation? https://www.ajmc.com/newsroom/do-breakthrough-therapies-need-more-rigorous-evaluation- Evidence-Based Oncology - July 2018: https://www.ajmc.com/journals/evidence-based-oncology/2018/july-2018
  continue reading

594 episoder

Artwork
iconDel
 
Manage episode 213294051 series 1314490
Innhold levert av Managed Care Cast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Managed Care Cast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care stories included patient advocates, providers, payers, and pharma commenting on the Trump administration's drug pricing plan; a survey that found physicians and payers believe progress toward value-based care is slowing; a study that questions the standards of evidence for breakthrough therapy approvals. Read more about the stories in this podcast: From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs: https://www.ajmc.com/newsroom/from-patient-advocates-to-pharma-groups-weigh-in-on-trump-blueprint-for-drug-costs Novartis Will Freeze Drug Prices Through End of 2018, CEO Says: https://www.ajmc.com/newsroom/novartis-will-freeze-drug-prices-through-end-of-2018-ceo-says What We're Reading: 340B Lawsuit to Be Refiled; Digging Into Breakthrough Approvals; Screen Time and ADHD: https://www.ajmc.com/newsroom/what-were-reading-340b-lawsuit-to-be-refiled-digging-into-breakthrough-approvals-screen-time-and-adhd Pause in Risk Adjustment Payments Announced, CMS Blames District Court's Decision: https://www.ajmc.com/newsroom/pause-in-risk-adjustment-payments-announced-cms-blames-district-courts-decision Doctors, Payers Think Transition to Value-Based Care Has Slowed, Survey Says: https://www.ajmc.com/newsroom/doctors-payers-think-transition-to-valuebased-care-has-slowed-survey-says Do Breakthrough Therapies Need More Rigorous Evaluation? https://www.ajmc.com/newsroom/do-breakthrough-therapies-need-more-rigorous-evaluation- Evidence-Based Oncology - July 2018: https://www.ajmc.com/journals/evidence-based-oncology/2018/july-2018
  continue reading

594 episoder

All episodes

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2025 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett
Lytt til dette showet mens du utforsker
Spill